165 related articles for article (PubMed ID: 21236362)
21. Prevention of periprocedural ischemic stroke and management of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration.
Kuwahara T; Takahashi A; Takahashi Y; Kobori A; Miyazaki S; Takei A; Fujino T; Okubo K; Takagi K; Fujii A; Takigawa M; Watari Y; Hikita H; Sato A; Aonuma K
J Cardiovasc Electrophysiol; 2013 May; 24(5):510-5. PubMed ID: 23350877
[TBL] [Abstract][Full Text] [Related]
22. Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.
Gianni C; DI Biase L; Mohanty S; Trivedi C; Bai R; Al-Ahmad A; Burkhardt JD; Gallinghouse GJ; Horton RP; Sanchez JE; Hranitzky PM; Lakkireddy D; Mansour MC; Santangeli P; Zado ES; Marchlinski FE; Beheiry S; Hao SC; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2016 Apr; 27(4):399-403. PubMed ID: 26756289
[TBL] [Abstract][Full Text] [Related]
23. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures.
Michowitz Y; Rahkovich M; Oral H; Zado ES; Tilz R; John S; Denis A; Di Biase L; Winkle RA; Mikhaylov EN; Ruskin JN; Yao Y; Josephson ME; Tanner H; Miller JM; Champagne J; Della Bella P; Kumagai K; Defaye P; Luria D; Lebedev DS; Natale A; Jais P; Hindricks G; Kuck KH; Marchlinski FE; Morady F; Belhassen B
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):274-80. PubMed ID: 24519888
[TBL] [Abstract][Full Text] [Related]
24. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
[TBL] [Abstract][Full Text] [Related]
25. Surgical intervention for cardiac tamponade during atrial fibrillation ablation: who and when?-a single-center experience.
Wu N; Wu F; Yang G; Ju W; Li M; Chen H; Gu K; Wang Z; Liu H; Zhang Y; Chen M
J Interv Card Electrophysiol; 2021 Nov; 62(2):373-380. PubMed ID: 33155173
[TBL] [Abstract][Full Text] [Related]
26. [The timing of pericardial drainage catheter removal and restart of the anticoagulation in patients suffered from perioperative pericardial tamponade during atrial fibrillation catheter ablation and uninterrupted dabigatran: Experiences from 20 cases].
Zhao X; Dai WL; Su X; Wu JH; Jia CQ; Feng L; Ning M; Ruan YF; Zuo S; Hu R; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jan; 51(1):45-50. PubMed ID: 36655241
[No Abstract] [Full Text] [Related]
27. Complications of transseptal catheterization for different cardiac procedures.
Katritsis GD; Siontis GC; Giazitzoglou E; Fragakis N; Katritsis DG
Int J Cardiol; 2013 Oct; 168(6):5352-4. PubMed ID: 24012276
[TBL] [Abstract][Full Text] [Related]
28. Two cases of delayed cardiac tamponade due to pericarditis after pulmonary vein (PV) isolation for atrial fibrillation.
Torihashi S; Shiraishi H; Hamaoka T; Imai M; Kuroyanagi A; Nakanishi N; Nakamura T; Yamano T; Matsumuro A; Shirayama T
Intern Med; 2015; 54(7):791-6. PubMed ID: 25832943
[TBL] [Abstract][Full Text] [Related]
29. Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin.
Saad EB; Costa IP; Costa RE; Inácio LA; Slater C; Camiletti A; Moura Neto DG; Maldonado P; Camanho LE; Polanczky CA
Arq Bras Cardiol; 2011 Oct; 97(4):289-96. PubMed ID: 21861038
[TBL] [Abstract][Full Text] [Related]
30. Management of Tamponade Complicating Catheter Ablation for Atrial Fibrillation: Early Removal of Pericardial Drains Is Safe and Effective and Reduces Analgesic Requirements and Hospital Stay Compared to Conventional Delayed Removal.
Pedersen MEF; Leo M; Kalla M; Malhotra A; Stone M; Wong K; Rajappan K; Ginks M; Betts TR; Bashir Y
JACC Clin Electrophysiol; 2017 Apr; 3(4):367-373. PubMed ID: 29759449
[TBL] [Abstract][Full Text] [Related]
31. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
Piccini JP; Stevens SR; Lokhnygina Y; Patel MR; Halperin JL; Singer DE; Hankey GJ; Hacke W; Becker RC; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Breithardt G;
J Am Coll Cardiol; 2013 May; 61(19):1998-2006. PubMed ID: 23500298
[TBL] [Abstract][Full Text] [Related]
32. Effect of catheter ablation and periprocedural anticoagulation regimen on the clinical course of migraine in atrial fibrillation patients with or without pre-existent migraine: results from a prospective study.
Mohanty S; Mohanty P; Rutledge JN; Di Biase L; Yan RX; Trivedi C; Santangeli P; Bai R; Cardinal D; Burkhardt JD; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Hranitzky PM; Zagrodzky J; Al-Ahmad A; Natale A
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):279-87. PubMed ID: 25682124
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study.
Di Biase L; Lakkireddy D; Trivedi C; Deneke T; Martinek M; Mohanty S; Mohanty P; Prakash S; Bai R; Reddy M; Gianni C; Horton R; Bailey S; Sigmund E; Derndorfer M; Schade A; Mueller P; Szoelloes A; Sanchez J; Al-Ahmad A; Hranitzky P; Gallinghouse GJ; Hongo RH; Beheiry S; Pürerfellner H; Burkhardt JD; Natale A
Heart Rhythm; 2015 Jun; 12(6):1162-8. PubMed ID: 25728754
[TBL] [Abstract][Full Text] [Related]
34. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.
Kang JH; Lee DI; Kim S; Kim MN; Park YM; Ban JE; Choi JI; Lim HE; Park SW; Kim YH
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and safety of percutaneous epicardial access for mapping and ablation for ventricular arrhythmias in patients on oral anticoagulants.
Miyamoto K; Killu AM; Kella DK; Hodge DO; Kapa S; Mulpuru SK; Deshmukh AJ; Packer DL; Asirvatham SJ; Munger TM; Friedman PA
J Interv Card Electrophysiol; 2019 Jan; 54(1):81-89. PubMed ID: 30232687
[TBL] [Abstract][Full Text] [Related]
36. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
37. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary vein antrum isolation for atrial fibrillation on therapeutic coumadin: special considerations.
Gopinath D; Lewis WR; Di Biase L; Natale A
J Cardiovasc Electrophysiol; 2011 Feb; 22(2):236-9. PubMed ID: 21044211
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
40. Safety of catheter ablation for atrial fibrillation in patients with intracranial hemorrhage.
Lin H; Li SN; Bai R; Wen SN; Liu N; Long DY; Yu RH; Tang RB; Sang CH; Du X; Dong JZ; Ma CS
Herz; 2018 Mar; 43(2):169-176. PubMed ID: 28314875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
